Back
Sanara MedTech Quote, Financials, Valuation and Earnings
Sponsored
SMTI
Sponsored
The Trump Nuclear MEGA-Boom!
Here's why nuclear stocks are expected to skyrocket under Trump's second term.
Sell
44
SMTI
Sanara MedTech
Last Price:
31.80
Seasonality Move:
75.56%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's Legacy-Defining Momentor Strike
But the Surprising Way Trump Solves it Could Cement His Legacy.Sanara MedTech Price Quote
$31.80
+0.01 (+0.03%)
(Updated: December 19, 2024 at 5:56 PM ET)
Sanara MedTech Key Stats
Sell
44
Sanara MedTech (SMTI)
is a Sell
Day range:
$31.44 - $34.22
52-week range:
$26.00 - $43.25
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
3.68
P/B ratio:
7.47%
Volume:
35.7K
Avg. volume:
33.9K
1-year change:
-15.47%
Market cap:
$297.1M
Revenue:
$65M
EPS:
$-0.99
How Much Does Sanara MedTech Make?
-
How Much Are Sanara MedTech's Sales Annually?
SMTI Revenues are $65M -
How Much Profit Does Sanara MedTech's Make A Year?
SMTI net income is -$4.3M
Is Sanara MedTech Growing As A Company?
-
What Is Sanara MedTech's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.35% -
What Is Sanara MedTech's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Sanara MedTech Stock Price Performance
-
Did Sanara MedTech Stock Go Up Last Month?
Sanara MedTech share price went down by -10.12% last month -
Did SMTI's Share Price Rise Over The Last Year?
SMTI share price fell by -15.47% over the past 1 year
What Is Sanara MedTech 52-Week High & Low?
-
What Is Sanara MedTech’s 52-Week High Share Price?
Sanara MedTech has traded as high as $43.25 over the past 52 weeks -
What Is Sanara MedTech’s 52-Week Low Share Price?
Sanara MedTech has traded as low as $26.00 over the past 52 weeks
Sanara MedTech Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Sanara MedTech?
-
How Much Debt Does Sanara MedTech Have?
Total long term debt quarterly is $30.1M -
How Much Cash Does Sanara MedTech Have?
Cash and short term investments quarterly total is $16.3M -
What Is Sanara MedTech’s Book Value Per Share?
Book value per share is 4.55
Is Sanara MedTech Cash Flow Positive?
-
What Is SMTI Cash Flow From Operations?
Cash flow from operations (TTM) is -$1.8M -
What Is Sanara MedTech’s Cash Flow From Financing?
Cash flow from financing (TTM) is $18.4M -
What Is Sanara MedTech’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$6.5M
Sanara MedTech Return On Invested Capital
-
Is Management Doing A Good Job?
SMTI return on invested capital is -14.62% -
What Is Sanara MedTech Return On Assets?
ROA measures how assets are converting to revenues and is -10.94% -
What Is SMTI Return On Equity?
ROE is a measure of profitability and is -19.67%
Sanara MedTech Earnings Date & Stock Price
-
What Is Sanara MedTech's Stock Price Today?
A single share of SMTI can be purchased today for 31.79 -
What Is Sanara MedTech’s Stock Symbol?
Sanara MedTech trades on the nasdaq under the ticker symbol: SMTI -
When Is Sanara MedTech’s Next Earnings Date?
The next quarterly earnings date for Sanara MedTech is scheduled on March 25, 2025 -
When Is SMTI's next ex-dividend date?
Sanara MedTech's next ex-dividend date is December 19, 2024 -
How To Buy Sanara MedTech Stock?
You can buy Sanara MedTech shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Sanara MedTech Competitors
-
Who Are Sanara MedTech's Competitors?
Below is a list of companies who compete with Sanara MedTech or are related in some way:
Sanara MedTech Dividend Yield
-
What Is SMTI Dividend Yield?
Sanara MedTech’s dividend yield currently is 0% -
What Is Sanara MedTech’s Payout Ratio?
Sanara MedTech’s payout ratio is 0% -
When Did Sanara MedTech Last Pay A Dividend?
The latest dividend pay date is December 19, 2024 -
What Is Sanara MedTech’s Dividend Per Share?
Sanara MedTech pays a dividend of $0.00 per share
Sanara MedTech Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 0% |
Revenue: | 35.24% | 4.69% |
Analyst Recommendations
Buy Recommendations: | 1 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 44.00 |
Upside from Last Price: | 38.41% |